Comparison
Abnormal Circulating Ornithine Concentration C4023070 vs Abnormal Auditory Evoked Potentials C0522216
Clinical comparison between Abnormal Circulating Ornithine Concentration and Abnormal Auditory Evoked Potentials for differential diagnosis and treatment planning.
Abnormal Circulating Ornithine Concentration C4023070
Ornithine is an amino acid involved in the urea cycle, which helps remove ammonia from the body. Abnormal levels may suggest liver dysfunction or certain metabolic disorders and require medical evaluation.
Abnormal Auditory Evoked Potentials C0522216
An abnormal brain response to sound, detected through specialized testing. It may indicate issues with hearing pathways or neurological conditions and requires further evaluation by specialists.
6 comparison axes
Onset
Abnormal Circulating Ornithine Concentration C4023070
Variable
Abnormal Auditory Evoked Potentials C0522216
Variable
Onset patterns differ
Severity
Abnormal Circulating Ornithine Concentration C4023070
moderate
Abnormal Auditory Evoked Potentials C0522216
moderate
Different severity levels
Chronic
Abnormal Circulating Ornithine Concentration C4023070
Chronic
Abnormal Auditory Evoked Potentials C0522216
Chronic
Differing course
Communicable
Abnormal Circulating Ornithine Concentration C4023070
No
Abnormal Auditory Evoked Potentials C0522216
No
Different transmission
Body System
Abnormal Circulating Ornithine Concentration C4023070
metabolic
Abnormal Auditory Evoked Potentials C0522216
neurologic
Same/different system
Category
Abnormal Circulating Ornithine Concentration C4023070
metabolic
Abnormal Auditory Evoked Potentials C0522216
neurologic
Different category
Bottom line
abnormal-circulating-ornithine-concentration-C4023070 and abnormal-auditory-evoked-potentials-C0522216 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abnormal Circulating Ornithine Concentration C4023070 | Abnormal Auditory Evoked Potentials C0522216 | Discriminating power |
|---|---|---|---|
| Primary clue | An abnormal blood ornithine result, with or without metabolic symptoms. | An abnormal sound-evoked neural response, with or without hearing or neurologic symptoms. | High |
| Associated context | May accompany suspected liver dysfunction, hyperammonemia, or an inherited metabolic disorder. | May accompany hearing-pathway, brainstem, or broader neurologic concerns. | Moderate |
| Clinical meaning | A laboratory abnormality requiring interpretation, not a confirmed diagnosis. | A neurophysiologic abnormality requiring interpretation, not a confirmed diagnosis. | High |
When to favor each condition
Choose Abnormal Circulating Ornithine Concentration C4023070 when
Unexplained metabolic or liver concern
Ornithine testing addresses amino-acid and urea-cycle-related possibilities.
Moderate
Abnormal amino-acid profile
The result may help direct metabolic evaluation, but does not prove a specific disorder.
Moderate
Need to assess ammonia-related metabolism
Ornithine participates in the urea cycle, so clinicians may consider related testing.
Low
Choose Abnormal Auditory Evoked Potentials C0522216 when
Suspected hearing-pathway dysfunction
Auditory evoked potentials evaluate neural responses to sound rather than blood chemistry.
High
Neurologic symptoms needing pathway testing
The study may support further neurologic or audiologic assessment.
Moderate
Objective auditory response is needed
It can provide physiologic information when behavioral hearing assessment is limited.
Moderate
How key tests differ
| Test | Abnormal Circulating Ornithine Concentration C4023070 | Abnormal Auditory Evoked Potentials C0522216 | Interpretation |
|---|---|---|---|
| Plasma amino acids | May show abnormal ornithine; exact cutoffs are not established here. | Not expected to characterize auditory pathway responses. | Interpret with the full amino-acid pattern and clinical context. |
| Auditory evoked potentials | Not a test of circulating ornithine. | May show delayed, reduced, or otherwise abnormal responses. | Abnormality suggests pathway dysfunction but does not identify its cause. |
| Ammonia or liver studies | May be considered when a metabolic or hepatic cause is suspected. | Not routinely explanatory for an isolated evoked-potential abnormality. | Selection depends on symptoms; no universal panel is established. |
Prognosis comparison
Abnormal Circulating Ornithine Concentration C4023070
- Outcome
- Outcome depends on the cause, which is not established by ornithine alone.
- Factors
- Trend, related amino acids, ammonia, liver status, and symptoms may matter.
Abnormal Auditory Evoked Potentials C0522216
- Outcome
- Outcome depends on the auditory or neurologic cause, which testing alone may not identify.
- Factors
- Waveform pattern, hearing, neurologic findings, and reversibility may matter.
Time frame: No reliable shared time frame is established.
Cause, associated abnormalities, and response to clinician-directed care are central.
Complications comparison
| Complication | Presentation |
|---|---|
| Missed underlying disorder | A metabolic or hepatic condition could be overlooked if the result is dismissed. Hearing or neurologic disease could be overlooked without follow-up. Both require clinician-directed evaluation; complications are not predetermined. |
| Delayed specialist referral | May delay metabolic or hepatology assessment when indicated. May delay audiology, otology, or neurology assessment when indicated. The appropriate specialist depends on accompanying findings. |
| Overtreatment from overinterpretation | Treating the number as a diagnosis may lead to unnecessary interventions. Treating the waveform as a diagnosis may misdirect care. Neither result alone establishes cause, severity, or treatment. |
Patient education highlights
- HighResult versus diagnosis
An abnormal result signals a need for interpretation; it does not by itself confirm a disease.
- HighDifferent body systems
Ornithine concerns metabolism, while evoked potentials concern hearing-related neural pathways.
- MediumFollow-up
Bring prior results and symptoms to the clinician so repeat or related testing can be chosen appropriately.